Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
de Graaf, HIbrahim, M
Hill, A R
Gbesemete, D
Vaughan, A T
Gorringe, A
Preston, A
Buisman, A M
Faust, S N
Kester, K E
Berbers, G A M
Diavatopoulos, D A
Read, R C
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation.Published in
Clin Infect Dis 2020; 71(2):403-11PMID
31562530ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciz840
Scopus Count
Collections
Related articles
- A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
- Authors: Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergström J, Ljungman M, Törner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C
- Issue date: 2014
- Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
- Authors: Langley JM, Halperin SA, Boucher FD, Smith B, Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC)
- Issue date: 2004 Jul
- Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model.
- Authors: de Graaf H, Gbesemete D, Gorringe AR, Diavatopoulos DA, Kester KE, Faust SN, Read RC
- Issue date: 2017 Oct 11
- Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice.
- Authors: Soumana IH, Linz B, Dewan KK, Sarr D, Gestal MC, Howard LK, Caulfield AD, Rada B, Harvill ET
- Issue date: 2021 Aug
- Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
- Authors: Buddy Creech C, Jimenez-Truque N, Kown N, Sokolow K, Brady EJ, Yoder S, Solovay K, Rubin K, Noviello S, Hensel E, Selamawi S, Bakare A, Makowski M, Lu K
- Issue date: 2022 Nov 8